• Cytochrome P450 2B6 (CYP2B6) Genotyping
  • Drug Testing, Presumptive (Drug Screen), Urine
  • Acid Phosphatase, Total, Serum
  • SERPINA1 Gene Mutation Analysis
  • Metanephrines, Fractionated, 24 Hour, Urine
  • Carboxy-Tetrahydrocannabinol (THC), Confirmation, Urine
  • Fluphenazine, Serum
  • Biopsy, Lymph Node
  • Hereditary Peripheral Neuropathies Gene Mutation Panel, NGS
  • Treponema pallidum Antibody, FTA-ABS, IgG, IgM
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Opioid-use Disorder Pain Management Genotyping Panel
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Opioid-use Disorder Pain Management Genotyping Panel
Medical Test

Diseases (3)
Access to Opioid-use Disorder Pain Management Genotyping Panel is restricted.
Loading...